STOCK TITAN
  1. Home
  2. RYZB

RayzeBio (RYZB) Stock Price, News & Analysis

RYZB NASDAQ

Company Description

RayzeBio (NASDAQ: RYZB) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for RYZB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
59.9M
Shares outstanding

Latest News

View All
0.00%

Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform

acquisition
+0.02%

Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer

+0.11%

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

+100.85%

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

acquisition
+5.99%

RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update

earnings
+3.70%

RayzeBio to Participate in Upcoming Investor Conferences in November 2023

conferences

RayzeBio has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings, conferences, management, fda approval. View all RYZB news →

SEC Filings

View All

No SEC filings available for RYZB.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

RYZB Company Profile & Sector Positioning

RayzeBio (RYZB) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.